{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:48:41Z","timestamp":1791002921631,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","so-online.net","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.suronc.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T01:03:57Z","timestamp":1483751037000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6855-9754","authenticated-orcid":false,"given":"Henri","family":"Aza\u00efs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Estevez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-6516","authenticated-orcid":false,"given":"P\u00e9rine","family":"Foucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-4768","authenticated-orcid":false,"given":"Yohan","family":"Kerbage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Mordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Collinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2006.07.004","article-title":"\u201cOptimal\u201d cytoreduction for advanced epithelial ovarian cancer: a commentary","volume":"103","author":"Eisenkop","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"Supplement 3","key":"10.1016\/j.suronc.2017.01.001_bib2","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0959-8049(11)70152-6","article-title":"Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer","volume":"47","author":"Vergote","year":"2011","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2012.02.024","article-title":"Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining \u201coptimal\u201d residual disease","volume":"125","author":"Chang","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"13","key":"10.1016\/j.suronc.2017.01.001_bib4","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1245\/s10434-012-2446-8","article-title":"Impact of complete cytoreduction leaving No gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer","volume":"19","author":"Chang","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2017.01.001_bib5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2017.01.001_bib6","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.suronc.2017.01.001_bib8","series-title":"Cochrane Database of Systematic Reviews","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer [Internet]","author":"Elattar","year":"2011"},{"key":"10.1016\/j.suronc.2017.01.001_bib9","first-page":"CD008765","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","volume":"2","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4251\/wjgo.v2.i2.102","article-title":"Peritoneal carcinosis of ovarian origin","volume":"2","author":"Fagotti","year":"2010","journal-title":"World J. Gastrointest. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2017.01.001_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"issue":"9951","key":"10.1016\/j.suronc.2017.01.001_bib12","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib13","first-page":"332","article-title":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","volume":"50","author":"Elias","year":"2014","journal-title":"Eur. J. Cancer Oxf Engl. 1990"},{"issue":"12","key":"10.1016\/j.suronc.2017.01.001_bib14","first-page":"1175","article-title":"Towards a new standard in cytoreductive surgery for advanced ovarian cancer","volume":"96","author":"Querleu","year":"2009","journal-title":"Bull. Cancer (Paris)"},{"issue":"9","key":"10.1016\/j.suronc.2017.01.001_bib15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/IGC.0000000000000007","article-title":"Ovarian cancer: sites of recurrence","volume":"23","author":"Amate","year":"2013","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"5","key":"10.1016\/j.suronc.2017.01.001_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1525-1438.1995.05050346.x","article-title":"Intestinal obstruction in patients with advanced ovarian cancer","volume":"5","author":"Bais","year":"1995","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"2 Pt 1","key":"10.1016\/j.suronc.2017.01.001_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0090-8258(81)90148-7","article-title":"The management of ovarian-cancer-caused bowel obstruction","volume":"12","author":"Tunca","year":"1981","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2017.01.001_bib18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/IGC.0b013e31822127cd","article-title":"The utility of peritoneal biopsy and omentectomy in the upstaging of apparent early ovarian cancer","volume":"21","author":"Shroff","year":"2011","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajog.2006.08.043","article-title":"Occult metastasis in early ovarian cancers: risk factors and associated prognosis","volume":"196","author":"Ayhan","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.suronc.2017.01.001_bib20","first-page":"949","article-title":"Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma","volume":"80","author":"Soper","year":"1992","journal-title":"Obstet. Gynecol."},{"issue":"22","key":"10.1016\/j.suronc.2017.01.001_bib21","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1001\/jama.1983.03340220040030","article-title":"STaging laparotomy in early ovarian cancer","volume":"250","author":"Young","year":"1983","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1525-1438.1998.09783.x","article-title":"The yield of surgical staging in presumed early stage ovarian cancer: benefits or doubts?","volume":"8","author":"Schueler","year":"1998","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pdpdt.2011.08.003","article-title":"Photodiagnosis and photodynamic therapy of peritoneal metastasis of ovarian cancer","volume":"9","author":"Guyon","year":"2012","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2015.01.009","article-title":"Photodynamic diagnosis for detection of peritoneal carcinomatosis","volume":"195","author":"Almerie","year":"2015","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.suronc.2017.01.001_bib25","article-title":"Photodynamic diagnosis with 5-aminolevulinic acid for intraoperative detection of peritoneal metastases of ovarian cancer: a feasibility and dose finding study","author":"Hillemanns","year":"2016","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/gyno.1996.4502","article-title":"In\u00a0vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA)","volume":"66","author":"Major","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-3804(98)80080-7","article-title":"In\u00a0vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model","volume":"5","author":"Hornung","year":"1998","journal-title":"J.\u00a0Am. Assoc. Gynecol. Laparosc."},{"issue":"10","key":"10.1016\/j.suronc.2017.01.001_bib28","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s004640090056","article-title":"5-aminolevulinic acid-induced (ALA) fluorescence for the laparoscopic diagnosis of peritoneal metastasis. AST an experimental study","volume":"15","author":"Canis","year":"2001","journal-title":"Surg. Endosc."},{"issue":"11","key":"10.1016\/j.suronc.2017.01.001_bib29","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.bjc.6600958","article-title":"Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study","volume":"88","author":"L\u00fcdicke","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.suronc.2017.01.001_bib30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1562\/2006-04-13-RA-869","article-title":"Laparoscopic photodynamic diagnosis of ovarian cancer peritoneal micro metastasis: an experimental study","volume":"83","author":"Collinet","year":"2007","journal-title":"Photochem Photobiol."},{"issue":"4","key":"10.1016\/j.suronc.2017.01.001_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/pho.2007.2057","article-title":"Comparison of aminolevulinic acid- and hexylester aminolevulinate-induced protoporphyrin IX fluorescence for the detection of ovarian cancer in a rat model","volume":"25","author":"Regis","year":"2007","journal-title":"Photomed. Laser Surg."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/gyno.2002.6793","article-title":"Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model","volume":"87","author":"Chan","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2017.01.001_bib33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/lsm.20302","article-title":"Fluorescence staining of human ovarian cancer tissue following application of 5-aminolevulinic acid: fluorescence microscopy studies","volume":"38","author":"L\u00f6ning","year":"2006","journal-title":"Lasers Surg. Med."},{"issue":"8","key":"10.1016\/j.suronc.2017.01.001_bib34","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/cncr.20155","article-title":"Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX","volume":"100","author":"L\u00f6ning","year":"2004","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.suronc.2017.01.001_bib35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.2472","article-title":"Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-\u03b1 targeting: first in-human results","volume":"17","author":"van Dam","year":"2011","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.suronc.2017.01.001_bib36","doi-asserted-by":"crossref","first-page":"32144","DOI":"10.18632\/oncotarget.8282","article-title":"Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17","volume":"7","author":"Tummers","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.suronc.2017.01.001_bib37","first-page":"2929","article-title":"A\u00a0novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer","volume":"22","author":"Hoogstins","year":"2016","journal-title":"Am. Assoc. Cancer Res."},{"issue":"13","key":"10.1016\/j.suronc.2017.01.001_bib38","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1245\/s10434-014-3901-5","article-title":"Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma: results of a phase I trial","volume":"21","author":"Liu","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.suronc.2017.01.001_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pdpdt.2015.07.006","article-title":"Targeted approaches and innovative illumination solutions: a new era for photodynamic therapy applications in gynecologic oncology?","volume":"13","author":"Aza\u00efs","year":"2016","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib40","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","article-title":"A\u00a0systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"14","author":"Yan","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"20","key":"10.1016\/j.suronc.2017.01.001_bib41","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J.\u00a0Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2017.01.001_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","article-title":"A\u00a0systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma","volume":"18","author":"Yan","year":"2007","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. ESMO"},{"issue":"4","key":"10.1016\/j.suronc.2017.01.001_bib43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.soc.2012.07.007","article-title":"Current status and future directions Of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer","volume":"21","author":"Helm","year":"2012","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejso.2010.11.004","article-title":"Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer","volume":"37","author":"Deraco","year":"2011","journal-title":"Eur. J. Surg. Oncol. EJSO"},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejogrb.2011.04.036","article-title":"Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma","volume":"158","author":"Cascales","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"7","key":"10.1016\/j.suronc.2017.01.001_bib46","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1245\/s10434-014-3599-4","article-title":"Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC\/IV ovarian cancer","volume":"21","author":"Cascales-Campos","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2017.01.001_bib47","first-page":"753","article-title":"The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer","volume":"11","author":"Mu\u00f1oz-Casares","year":"2009","journal-title":"Clin. Transl. Oncol. Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex."},{"issue":"5","key":"10.1016\/j.suronc.2017.01.001_bib48","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.suronc.2017.01.001_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/IGC.0000000000000664","article-title":"Heated IntraPEritoneal chemotherapy (HIPEC) for patients with recurrent ovarian cancer: a systematic literature review","author":"Hotouras","year":"2016","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2013.04.001","article-title":"Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study","volume":"130","author":"Landrum","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.suronc.2017.01.001_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14694\/EDBK_158927","article-title":"Update on intraperitoneal chemotherapy for the treatment of epithelial ovarian cancer","volume":"35","author":"Gourley","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book ASCO Am. Soc. Clin. Oncol. Meet."},{"issue":"3","key":"10.1016\/j.suronc.2017.01.001_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0360-3016(93)90066-5","article-title":"Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors","volume":"25","author":"Delaney","year":"1993","journal-title":"Int. J. Radiat. Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2017.01.001_bib53","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1078-0432.CCR-05-1625","article-title":"A\u00a0phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis","volume":"12","author":"Hahn","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10434-001-0065-x","article-title":"Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors","volume":"8","author":"Hendren","year":"2001","journal-title":"Ann. Surg. Oncol."},{"issue":"18","key":"10.1016\/j.suronc.2017.01.001_bib55","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1158\/1078-0432.CCR-06-0953","article-title":"Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy","volume":"12","author":"Hahn","year":"2006","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.suronc.2017.01.001_bib56","first-page":"493","article-title":"Intraperitoneal photodynamic therapy","volume":"134","author":"Cengel","year":"2007","journal-title":"Cancer Treat. Res."},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1078\/0171-2985-00221","article-title":"The immunological consequences of photodynamic treatment of cancer, a literature review","volume":"207","author":"van Duijnhoven","year":"2003","journal-title":"Immunobiology"},{"issue":"Suppl 2","key":"10.1016\/j.suronc.2017.01.001_bib58","doi-asserted-by":"crossref","first-page":"S-40","DOI":"10.6004\/jnccn.2012.0173","article-title":"Photodynamic therapy and antitumor immunity","volume":"10","author":"Gollnick","year":"2012","journal-title":"J.\u00a0Natl. Compr. Canc Netw."},{"key":"10.1016\/j.suronc.2017.01.001_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pdpdt.2015.07.005","article-title":"Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study","volume":"13","author":"Aza\u00efs","year":"2016","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"12","key":"10.1016\/j.suronc.2017.01.001_bib60","first-page":"3380","article-title":"Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy","volume":"49","author":"Los","year":"1989","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.suronc.2017.01.001_bib61","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure","volume":"89","author":"Dedrick","year":"1997","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.suronc.2017.01.001_bib62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00276-008-0456-9","article-title":"Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas","volume":"31","author":"Albanese","year":"2009","journal-title":"Surg. Radiol. Anat."},{"issue":"12","key":"10.1016\/j.suronc.2017.01.001_bib63","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1684\/bdc.2014.1977","article-title":"FR\u03b1: a target for prophylactic photodynamic therapy of ovarian peritoneal metastasis?","volume":"101","author":"Aza\u00efs","year":"2014","journal-title":"Bull. Cancer (Paris)"},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.suronc.2017.01.001_bib65","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1200\/JCO.2002.20.5.1238","article-title":"Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer","volume":"20","author":"Dizon","year":"2002","journal-title":"J.\u00a0Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2017.01.001_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ygyno.2014.05.029","article-title":"Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysis","volume":"134","author":"Petrillo","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2017.01.001_bib67","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajog.2011.08.022","article-title":"Is comprehensive surgical staging needed for thorough evaluation of early-stage ovarian carcinoma?","volume":"206","author":"Garcia-Soto","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.suronc.2017.01.001_bib68","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2009.06.037","article-title":"Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration","volume":"115","author":"Powless","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2017.01.001_bib69","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1245\/s10434-014-3648-z","article-title":"The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer","volume":"21","author":"Lee","year":"2014","journal-title":"Ann. Surg. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416300883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416300883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:57:04Z","timestamp":1749855424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740416300883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0960740416300883"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2017.01.001","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}